Literature DB >> 12228906

Pediatric liver tumors and hepatic ontogenesis: common and distinctive pathways.

Arthur Zimmermann1.   

Abstract

Several types of pediatric liver tumors exhibit structural features apparently reflecting processes which normally occur during hepatic ontogenesis: some hepatoblastomas mimic distinct phases of hepatogenesis, including the formation of mesenchymal structures closely associated with immature epithelia, and there are tumors almost exclusively consisting of complex mesenchymal patterns. Current classifications of hepatoblastomas refer to the identification of more or less mature (differentiated) single or mixed components seen in histologic preparations. These do not, however, attempt to integrate ontogenic pathways, in contrast for example, to nephroblastoma and associated lesions, where such a view has proved to be highly fruitful. Based on the fact that an enormous amount of knowledge has recently been accumulated regarding hepatic ontogenesis, time may have come to look at these tumors with a new eye. In what follows, we aim at trying to analyze distinct features of pediatric hepatic tumors (except vascular tumors) within the background of ontogenesis. Some key steps of hepatogenesis and the regulatory factors involved may, in the future, deliver an armamentarium to search for novel molecular mechanisms involved in tumorigenic pathways. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12228906     DOI: 10.1002/mpo.10174

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  2 in total

Review 1.  'Teratoid' Hepatoblastoma: An Intriguing Variant of Mixed Epithelial-Mesenchymal Hepatoblastoma.

Authors:  Consolato M Sergi; Marta Rojas-Vasquez; Michelle Noga; Bryan Dicken
Journal:  Children (Basel)       Date:  2022-04-15

2.  HGF/c-Met related activation of β-catenin in hepatoblastoma.

Authors:  Rachel Purcell; Margaret Childs; Rudolf Maibach; Carina Miles; Clinton Turner; Arthur Zimmermann; Michael Sullivan
Journal:  J Exp Clin Cancer Res       Date:  2011-10-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.